Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2526
http://purl.obolibrary.org/obo/NCIT_C2526
|
|---|---|
| Preferred Name | Anhydrovinblastine |
| Definitions |
A semisynthetic derivative of the vinca alkaloid vinblastine, with potential antineoplastic activity. Like vinblastine, anhydrovinblastine targets and binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and causing tumor cell cycle arrest in the M phase.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A semisynthetic derivative of the vinca alkaloid vinblastine, with potential antineoplastic activity. Like vinblastine, anhydrovinblastine targets and binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and causing tumor cell cycle arrest in the M phase. |
|---|---|
| prefLabel | Anhydrovinblastine
|
| label | Anhydrovinblastine
|
| PDQ_Closed_Trial_Search_ID | 43460
|
| code | C2526
|
| prefixIRI | NCIT:C2526
|
| in_subset | |
| Preferred_Name | Anhydrovinblastine
|
| FDA_UNII_Code | 5B622U08B3
|
| Contributing_Source | FDA
|
| Maps_To | Anhydrovinblastine
|
| CAS_Registry | 38390-45-3
|
| NCI_Drug_Dictionary_ID | 43460
|
| Legacy Concept Name | Anhydrovinblastine
|
| type | |
| ALT_DEFINITION | An anticancer drug that belongs to the family of drugs called mitotic inhibitors.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 43460
|
| Semantic_Type |
Organic Chemical
Pharmacologic Substance
|
| UMLS_CUI | C0796616
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |